Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent

Keyphrases

• Epidermal Growth Factor 100%
• Epidermal Growth Factor Receptor 100%
• Vascular Smooth muscle Cells 100%
• Insulin 100%
• Domain-independent 100%
• Growth Factor Activation 100%
• Metalloproteinases 100%
• Disintegrin 100%
• HB-EGF 41%
• Receptor Phosphorylation 33%
• G Protein-coupled Receptor 16%
• AG1478 16%
• Plasmin Inhibitors 16%
• TAPI-1 16%
• Inhibitory Antibody 16%
• Tumor Necrosis Factor-α 8%
• Receptor Tyrosine Kinase 8%
• Culture in Vitro 8%
• Vasculature 8%
• Concentration-dependent 8%
• Tyrosine Kinase 8%
• Protease Inhibitors 8%
• Dependent Processes 8%
• Epidermal Growth Factor Receptor Inhibitors 8%
• Molecular Targets 8%
• Receptor Activation 8%
• Metabolic Syndrome 8%
• Transactivation 8%
• Epidermal Growth Factor Receptor Transactivation 8%
• Human Vascular Smooth muscle Cells 8%
• Plasmin 8%
• Matrix Metalloproteinase Inhibitors 8%
• Insulin Action 8%
• Insulin Signaling 8%
• Aprotinin 8%
• Aminocaproic Acid 8%
• Insulin-like Growth Factor 1 Receptor (IGF1R) 8%
• CRM197 8%
• GM6001 8%
• Matrix Metalloproteases 8%
• Epidermal Growth Factor Inhibitor 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Epidermal Growth Factor Receptor 100%
• Epidermal Growth Factor 100%
• Metalloproteinase 100%
• Disintegrin 100%
• Heparin Binding Epidermal Growth Factor 41%
• Receptor 25%
• Protein Tyrosine Kinase 16%
• G Protein Coupled Receptor 16%
• Plasmin Inhibitor 16%
• 4 (3 Chloroanilino) 6,7 Dimethoxyquinazoline 16%
• Aprotinin 8%
• Metabolic Syndrome X 8%
• Molecular Target 8%
• Proteinase Inhibitor 8%
• Plasmin 8%
• Epidermal Growth Factor Receptor Kinase Inhibitor 8%
• Aminocaproic Acid 8%
• Somatomedin 8%
• Ilomastat 8%
• Diphtheria Toxoid CRM197 8%
• Metalloproteinase Inhibitor 8%
• Tumor Necrosis Factor Inhibitor 8%

Biochemistry, Genetics and Molecular Biology

• Epidermal Growth Factor Receptor 100%
• Epidermal Growth Factor 100%
• A Disintegrin and Metalloproteinase 100%
• Heparin-Binding EGF-like Growth Factor 38%
• Plasmin 23%
• Fibrinolysin 23%
• Transactivation 15%
• G Protein Coupled Receptor 15%
• Receptor Cross-Talk 15%
• Receptor Tyrosine Kinase 7%
• Aprotinin 7%
• Tyrosine 7%
• Metalloproteinase 7%
• Metalloendopeptidase 7%
• Protease Inhibitor 7%
• Growth Factor Receptor Inhibitor 7%
• Metalloprotease Inhibitor 7%
• Vascularization 7%
• Insulin Signaling 7%
• TNF Inhibitor 7%